All stock lists
Skye Bioscience, Inc. (NASDAQ:SKYE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.54-0.08 (-4.94%)
Insider Score
––Not scored
SKYE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SKYE analyst forecast
Best analysts covering SKYE
No firm covering SKYE has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SKYE analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-06-24 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2025-03-21 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-03-21 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-09-20 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-09-20 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-09-09 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-09-06 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-08-27 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-07-01 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-06-18 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-06-17 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-03-14 |
SKYE earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-19 | -2.32 | -2.88 | $0 | $0 |
| 2026-05-11 | -0.29 | -0.32 | $0 | $0 |
| 2026-08-14 | -2.04 | -2.16 | $0 | $0 |
| 2026-11-09 | -1.14 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.